Literature DB >> 8828631

Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria.

I Lombeck1, F Jochum, K Terwolbeck.   

Abstract

The selenium status was investigated in 87 patients of the German Collaborative Study of Phenylketonuria (PKU) (mean age 9.7 years). The selenium values and glutathione peroxidase activity in plasma and erythrocytes were negatively correlated to the quality of dietary management (mean plasma phenylalanine value). Despite a low selenium state, the children showed no clinical sign of deficiency and almost all biochemical parameters checked were normal. In the low selenium state thyroxine values are increased and decline during selenium supplementation, whereas tri-iodothyronine and thyroid stimulating hormone levels remain unchanged. The reduction in glutathione peroxidase activity in plasma was more pronounced than in the erythrocytes pointing to a different availability of both enzymes for selenium. In addition we estimated the selenium status in 29 women with PKU during pregnancy. In 32 healthy pregnant women we observed a decrease in plasma selenium values and the glutathione peroxidase activity in the third trimester, whereas the erythrocyte glutathione peroxidase activity remained stable. In contrast to the healthy women we found in the PKU group a steady decrease of all selenium parameters tested during the whole pregnancy. During the long-term low-dose selenium supplementation in PKU children the glutathione peroxidase activity of plasma and erythrocytes increased. They reached a similar plateau after the application of inorganic or organic selenium compounds. In contrast the selenium values of plasma and whole blood showed only a plateau after the application of sodium selenite. The supplementation with low doses of selenium in the form of selenomethionine increased the plasma and whole blood selenium values constantly within the first 9 months. Therefore selenomethionine supplementation cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828631     DOI: 10.1007/pl00014232

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

1.  Iodine and selenium deficiency associated with cretinism in northern Zaire.

Authors:  J B Vanderpas; B Contempré; N L Duale; W Goossens; N Bebe; R Thorpe; K Ntambue; J Dumont; C H Thilly; A T Diplock
Journal:  Am J Clin Nutr       Date:  1990-12       Impact factor: 7.045

2.  Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme.

Authors:  D Behne; A Kyriakopoulos; H Meinhold; J Köhrle
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

3.  Plasma selenium levels in treated phenylketonuric patients.

Authors:  A Rottoli; G Lista; G Zecchini; C Butté; R Longhi
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  Macrocytosis and pseudoalbinism: manifestations of selenium deficiency.

Authors:  N E Vinton; K A Dahlstrom; C T Strobel; M E Ament
Journal:  J Pediatr       Date:  1987-11       Impact factor: 4.406

5.  Potentially life-threatening cardiac dysrhythmia in a child with selenium deficiency and phenylketonuria.

Authors:  L G Greeves; D J Carson; B G Craig; D McMaster
Journal:  Acta Paediatr Scand       Date:  1990-12

6.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

7.  Red blood cell glutathione peroxidase activity as a function of selenium supplementation in dietary treated children with phenylketonuria.

Authors:  B A Zachara; W Wasowicz; J Gromadzińska; M Skłodowska; B Cabalska
Journal:  Biomed Biochim Acta       Date:  1987

8.  Selenium concentration and glutathione peroxidase activity in blood of New Zealand infants and children.

Authors:  R L McKenzie; H M Rea; C D Thomson; M F Robinson
Journal:  Am J Clin Nutr       Date:  1978-08       Impact factor: 7.045

9.  The selenium status of children with phenylketonuria: results of selenium supplementation.

Authors:  A Lipson; H Masters; M O'Halloran; S Thompson; J Coveney; J Yu
Journal:  Aust Paediatr J       Date:  1988-04

10.  Studies on the relations of selenium and Keshan disease.

Authors:  X Chen; G Yang; J Chen; X Chen; Z Wen; K Ge
Journal:  Biol Trace Elem Res       Date:  1980-06       Impact factor: 3.738

View more
  5 in total

1.  Investigation of oxidative stress parameters in treated phenylketonuric patients.

Authors:  A Sitta; A G Barschak; M Deon; T Terroso; R Pires; R Giugliani; C S Dutra-Filho; M Wajner; C R Vargas
Journal:  Metab Brain Dis       Date:  2006-12-05       Impact factor: 3.584

2.  Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.

Authors:  A Sitta; C S Vanzin; G B Biancini; V Manfredini; A B de Oliveira; C A Y Wayhs; G O S Ribas; L Giugliani; I V D Schwartz; D Bohrer; S C Garcia; M Wajner; C R Vargas
Journal:  Cell Mol Neurobiol       Date:  2010-12-30       Impact factor: 5.046

Review 3.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Nutritional status of patients with phenylketonuria in Japan.

Authors:  Yoshiyuki Okano; Toshikazu Hattori; Hiroki Fujimoto; Kaori Noi; Miki Okamoto; Toshiaki Watanabe; Ryoko Watanabe; Rika Fujii; Tomoko Tamaoki
Journal:  Mol Genet Metab Rep       Date:  2016-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.